{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:19:16Z","timestamp":1784611156833,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-C-069"],"award-info":[{"award-number":["2022-PUMCH-C-069"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11858-7","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:29:00Z","timestamp":1761564540000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical characteristics and prognostic analysis of concurrent Pneumocystis jirovecii pneumonia in patients with malignancies: a retrospective study"],"prefix":"10.1186","volume":"25","author":[{"given":"Yujie","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"issue":"9","key":"11858_CR1","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1093\/jac\/dkw155","volume":"71","author":"C Cordonnier","year":"2016","unstructured":"Cordonnier C, Alanio A, Cesaro S, Maschmeyer G, Einsele H, Donnelly JP, et al. Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother. 2016;71(9):2379\u201385.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"11858_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.pulmoe.2019.04.003","volume":"25","author":"I Rego de Figueiredo","year":"2019","unstructured":"Rego de Figueiredo I, Vieira Alves R, Drummond Borges D, Torres M, Louren\u00e7o F, Antunes AM, et al. Pneumocystosis pneumonia: A comparison study between HIV and non-HIV immunocompromised patients. Pulmonology. 2019;25(5):271\u20134.","journal-title":"Pulmonology"},{"issue":"7","key":"11858_CR3","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","volume":"24","author":"DW Denning","year":"2024","unstructured":"Denning DW. Global incidence and mortality of severe fungal disease. Lancet Infect Dis. 2024;24(7):e428\u201338.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"11858_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06144-1","volume":"21","author":"S Gr\u00f8nseth","year":"2021","unstructured":"Gr\u00f8nseth S, Rogne T, Hannula R, \u00c5svold BO, Afset JE, Dam\u00e5s JK. Epidemiological and clinical characteristics of immunocompromised patients infected with Pneumocystis jirovecii in a twelve-year retrospective study from Norway. BMC Infect Dis. 2021;21(1):659.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"11858_CR5","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.jmii.2019.08.012","volume":"53","author":"SL Yang","year":"2020","unstructured":"Yang SL, Wen YH, Wu YS, Wang MC, Chang PY, Yang S, et al. Diagnosis of pneumocystis pneumonia by real-time PCR in patients with various underlying diseases. J Microbiol Immunol Infect. 2020;53(5):785\u201390.","journal-title":"J Microbiol Immunol Infect"},{"issue":"9","key":"11858_CR6","first-page":"881","volume":"45","author":"RX Chen","year":"2022","unstructured":"Chen RX, Sun YX, Liu XN, Shao C, Huang H, Hu K, et al. Host factors and characteristics of hospitalized patients with Pneumocystis jirovecii pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 2022;45(9):881\u20137.","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"issue":"9","key":"11858_CR7","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1093\/jac\/dkw157","volume":"71","author":"J Maertens","year":"2016","unstructured":"Maertens J, Cesaro S, Maschmeyer G, Einsele H, Donnelly JP, Alanio A, et al. ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother. 2016;71(9):2397\u2013404.","journal-title":"J Antimicrob Chemother"},{"issue":"30","key":"11858_CR8","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1200\/JCO.18.00374","volume":"36","author":"RA Taplitz","year":"2018","unstructured":"Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK, et al. Antimicrobial prophylaxis for adult patients with Cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update. J Clin Oncol. 2018;36(30):3043\u201354.","journal-title":"J Clin Oncol"},{"issue":"02","key":"11858_CR9","first-page":"81","volume":"17","author":"AIDS and Hepatitis C Professional Group, Society of Infectious Diseases, Chinese Medical Association","year":"2024","unstructured":"AIDS and Hepatitis C Professional Group, Society of Infectious Diseases, Chinese Medical Association. Chinese expert consensus on diagnosis and treatment of Pneumocystis pneumonia in AIDS patients (2024 edition). Chin J Clin Infect Dis. 2024;17(02):81\u20139298.","journal-title":"Chin J Clin Infect Dis"},{"issue":"35","key":"11858_CR10","doi-asserted-by":"publisher","first-page":"59729","DOI":"10.18632\/oncotarget.19927","volume":"8","author":"Y Liu","year":"2017","unstructured":"Liu Y, Su L, Jiang SJ, Qu H. Risk factors for mortality from Pneumocystis carinii pneumonia (PCP) in non-HIV patients: a meta-analysis. Oncotarget. 2017;8(35):59729\u201339.","journal-title":"Oncotarget"},{"issue":"5","key":"11858_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.medmal.2014.01.007","volume":"44","author":"A Roux","year":"2014","unstructured":"Roux A, Gonzalez F, Roux M, Mehrad M, Menotti J, Zahar JR, et al. Update on pulmonary Pneumocystis jirovecii infection in non-HIV patients. Med Mal Infect. 2014;44(5):185\u201398.","journal-title":"Med Mal Infect"},{"issue":"1","key":"11858_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-14-87","volume":"14","author":"V Lemiale","year":"2013","unstructured":"Lemiale V, Debrumetz A, Delannoy A, Alberti C, Azoulay E. Adjunctive steroid in HIV-negative patients with severe Pneumocystis pneumonia. Respir Res. 2013;14(1):87.","journal-title":"Respir Res"},{"issue":"1","key":"11858_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-019-0604-x","volume":"9","author":"BJ Gaborit","year":"2019","unstructured":"Gaborit BJ, Tessoulin B, Lavergne RA, Morio F, Sagan C, Canet E, et al. Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study. Ann Intensive Care. 2019;9(1):131.","journal-title":"Ann Intensive Care"},{"issue":"7","key":"11858_CR14","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jiac.2014.03.003","volume":"20","author":"DP Kofteridis","year":"2014","unstructured":"Kofteridis DP, Valachis A, Velegraki M, Antoniou M, Christofaki M, Vrentzos GE, et al. Predisposing factors, clinical characteristics and outcome of pneumonocystis jirovecii pneumonia in HIV-negative patients. J Infect Chemother. 2014;20(7):412\u20136.","journal-title":"J Infect Chemother"},{"issue":"1","key":"11858_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08727-2","volume":"21","author":"K Takeda","year":"2021","unstructured":"Takeda K, Harada S, Hayama B, Hoashi K, Enokida T, Sasaki T, et al. Clinical characteristics and risk factors associated with Pneumocystis jirovecii infection in patients with solid tumors: study of thirteen-year medical records of a large cancer center. BMC Cancer. 2021;21(1):987.","journal-title":"BMC Cancer"},{"key":"11858_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.680108","volume":"9","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhou X, Saimi M, Huang X, Sun T, Fan G, et al. Risk factors of mortality from Pneumocystis pneumonia in non-HIV patients: a meta-analysis. Front Public Health. 2021;9:680108.","journal-title":"Front Public Health"},{"issue":"1","key":"11858_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06124-5","volume":"21","author":"F Jin","year":"2021","unstructured":"Jin F, Xie J, Wang HL. Lymphocyte subset analysis to evaluate the prognosis of HIV-negative patients with Pneumocystis pneumonia. BMC Infect Dis. 2021;21(1):441.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"11858_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10096-022-04518-0","volume":"42","author":"J Zhang","year":"2023","unstructured":"Zhang J, Sun X, Xu J, Gu X, Chen Q, Gao J, et al. Outcomes and factors contributing to poor prognosis of Pneumocystis jirovecii pneumonia in HIV-negative patients: a cross-sectional retrospective study in a Chinese single center. Eur J Clin Microbiol Infect Dis. 2023;42(1):109\u201312.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"11858_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0296758","volume":"19","author":"A Perret","year":"2024","unstructured":"Perret A, Le Marechal M, Germi R, Maubon D, Garnaud C, Noble J, et al. Cytomegalovirus detection is associated with ICU admission in non-AIDS and AIDS patients with Pneumocystis jirovecii pneumonia. PLoS ONE. 2024;19(1):e0296758.","journal-title":"PLoS ONE"},{"issue":"1","key":"11858_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2492-8","volume":"17","author":"Q Yu","year":"2017","unstructured":"Yu Q, Jia P, Su L, Zhao H, Que C. Outcomes and prognostic factors of non-HIV patients with Pneumocystis jirovecii pneumonia and pulmonary CMV co-infection: a retrospective cohort study. BMC Infect Dis. 2017;17(1):392.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"11858_CR21","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1093\/infdis\/jiab460","volume":"225","author":"R L\u00e9cuyer","year":"2022","unstructured":"L\u00e9cuyer R, Issa N, Tessoulin B, Lavergne RA, Morio F, Gabriel F, et al. Epidemiology and clinical impact of respiratory coinfections at diagnosis of Pneumocystis jirovecii pneumonia. J Infect Dis. 2022;225(5):868\u201380.","journal-title":"J Infect Dis"},{"key":"11858_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-14-182","volume":"14","author":"CW Chou","year":"2014","unstructured":"Chou CW, Lin FC, Tsai HC, Chang SC. The impact of concomitant pulmonary infection on immune dysregulation in Pneumocystis jirovecii pneumonia. BMC Pulm Med. 2014;14:182.","journal-title":"BMC Pulm Med"},{"issue":"1","key":"11858_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ijid.2008.03.027","volume":"13","author":"V Boonsarngsuk","year":"2009","unstructured":"Boonsarngsuk V, Sirilak S, Kiatboonsri S. Acute respiratory failure due to Pneumocystis pneumonia: outcome and prognostic factors. Int J Infect Dis. 2009;13(1):59\u201366.","journal-title":"Int J Infect Dis"},{"issue":"4","key":"11858_CR24","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s00277-023-05586-8","volume":"103","author":"C Riedhammer","year":"2024","unstructured":"Riedhammer C, D\u00fcll J, Kestler C, Kadel S, Franz J, Weis P, et al. Dismal prognosis of Pneumocystis jirovecii pneumonia in patients with multiple myeloma. Ann Hematol. 2024;103(4):1327\u201332.","journal-title":"Ann Hematol"},{"issue":"6","key":"11858_CR25","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s00277-021-04452-9","volume":"100","author":"AY Classen","year":"2021","unstructured":"Classen AY, Henze L, von Lilienfeld-Toal M, Maschmeyer G, Sandherr M, Graeff LD, et al. Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the infectious diseases working party of the German society of hematology and medical oncology (AGIHO\/DGHO). Ann Hematol. 2021;100(6):1603\u201320.","journal-title":"Ann Hematol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11858-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11858-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11858-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:06:21Z","timestamp":1761847581000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11858-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11858"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11858-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Peking Union Medical College Hospital (K5596) in accordance with the Declaration of Helsinki. Written informed consent from each patient was waived because our study was conducted using anonymized health care data, which met the IRB\u2019s minimal risk waiver criteria.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1408"}}